Author:
Momin Mohammad A.M.,Thien Sim J.,Krittaphol Woravimol,Das Shyamal C.
Funder
Health Research Council of New Zealand
Fred Fastier Trust
University of Otago
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference22 articles.
1. Global Tuberculosis Report 2015,2015
2. Phase I, single-dose, dose-escalating study of inhaled dry powder capreomycin: a new approach to therapy of drug-resistant tuberculosis;Dharmadhikari;Antimicrob. Agents Chemother.,2013
3. Powerful bactericidal and sterilizing activity of a regimen containing PA-824 moxifloxacin, and pyrazinamide in a murine model of tuberculosis;Nuermberger;Antimicrob. Agents Chemother.,2008
4. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial;Diacon;Lancet,2012
5. PA-824, moxifloxacin and pyrazinamide combination therapy for tuberculosis;Dawson;Expert Opin. Investig. Drugs,2013
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献